Showing results (221-230 of 300) with videos related to

Sort By:
Pageof 30
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2024
Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide-Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196Stéphane De Wit, Fabrice Bonnet, Olayemi Osiyemi, et al.
Diabetes & Metabolism|August 7, 2021
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statementJerome Boursier, Rodolphe Anty, Claire Carette, et al.
Journal of Hepatology|April 10, 2019
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategiesGilles Wandeler, Etienne Mauron, Andrew Atkinson, et al.
BMC Infectious Diseases|October 11, 2013
Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort studySigne W Worm, Mark Bower, Peter Reiss, et al.
AIDS (London, England)|October 26, 2012
An internationally generalizable risk index for mortality after one year of antiretroviral therapyJanet P Tate, Amy C Justice, Michael D Hughes, et al.
AIDS (London, England)|August 3, 2023
Frailty and prefrailty phenotypes increase the odds of abnormal cognitive impairment screens in people with HIVAlain Makinson, Clotilde Allavena, Xian Abulizi, et al.
Journal of Autoimmunity|September 1, 2015
Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literatureBenjamin Terrier, Isabelle Marie, Adeline Lacraz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2009
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal, Amanda Mocroft, Jonathan A C Sterne, et al.
Pageof 30